Literature DB >> 16801824

Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies.

William W McDaniel1, Anupinder K Sahota, Barin V Vyas, Nena Laguerta, Liana Hategan, Jessica Oswald.   

Abstract

Ten patients treated with electroconvulsive therapy (ECT) for depressive illness received anesthesia with either etomidate or ketamine. Three patients received both etomidate and ketamine anesthesia for ECT during separate episodes of depression. Patients anesthetized with ketamine for ECT had significantly less impairment of short-term memory function than did patients who received ECT with etomidate anesthesia. All patients who received both anesthetics for ECT during 2 different episodes had less memory loss during ECT with ketamine than with etomidate. These results show the importance of studying the effects of all anesthetic agents used during ECT on cognitive functions. The results imply that the effect of ECT on memory may be largely caused by effects mediated by glutamate at N-methyl-d-aspartate receptors and suggest that N-methyl-d-aspartate antagonists may offer protection from memory dysfunction during ECT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801824     DOI: 10.1097/00124509-200606000-00005

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  29 in total

1.  Long-term decrease in immediate early gene expression after electroconvulsive seizures.

Authors:  Julien Braga Calais; Samira S Valvassori; Wilson R Resende; Gustavo Feier; Maria Carolina Pedro Athié; Sidarta Ribeiro; Wagner Farid Gattaz; João Quevedo; Elida Benquique Ojopi
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

Review 2.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

3.  Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial.

Authors:  Tony Yen; Mohamad Khafaja; Nicholas Lam; James Crumbacher; Ronald Schrader; John Rask; Mary Billstrand; Jacob Rothfork; Christopher C Abbott
Journal:  J ECT       Date:  2015-03       Impact factor: 3.635

4.  A Randomized Pilot Study Comparing Ketamine and Methohexital Anesthesia for Electroconvulsive Therapy in Patients With Depression.

Authors:  Shona L Ray-Griffith; Lou Ann Eads; Xiaotong Han; Kimberly Golden; Zachary N Stowe
Journal:  J ECT       Date:  2017-12       Impact factor: 3.635

5.  S -ketamine compared to etomidate during electroconvulsive therapy in major depression.

Authors:  Maxim Zavorotnyy; Ina Kluge; Kathrin Ahrens; Thomas Wohltmann; Benjamin Köhnlein; Patricia Dietsche; Udo Dannlowski; Tilo Kircher; Carsten Konrad
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-19       Impact factor: 5.270

6.  Ketofol in electroconvulsive therapy anesthesia: two stones for one bird.

Authors:  Saban Yalcin; Harun Aydoğan; Salih Selek; Ahmet Kucuk; Hasan Husnu Yuce; Fatih Karababa; Tekin Bilgiç
Journal:  J Anesth       Date:  2012-05-24       Impact factor: 2.078

7.  Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.

Authors:  Murat Altinay; Harish Karne; Amit Anand
Journal:  Psychopharmacol Bull       Date:  2019-02-15

8.  Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia.

Authors:  Nandakumar Nagaraja; Chittaranjan Andrade; Suresh Sudha; Nagendra Madan Singh; J Suresh Chandra; B V Venkataraman
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

9.  Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.

Authors:  Chadi G Abdallah; Madonna Fasula; Ben Kelmendi; Gerard Sanacora; Robert Ostroff
Journal:  J ECT       Date:  2012-09       Impact factor: 3.635

Review 10.  Ketamine administration in depressive disorders: a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Corentin Rabu; Alexandra Macgregor; Christophe Lançon; Marie Brittner; Jean-Arthur Micoulaud-Franchi; Raphaelle Richieri; Philippe Courtet; Mocrane Abbar; Matthieu Roger; Marion Leboyer; Laurent Boyer
Journal:  Psychopharmacology (Berl)       Date:  2014-07-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.